Delivery Order SPE2DB20D2002-SPE2DB21FL17X
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,854.80 delivery order contract is for the Prime Vendor Pharmaceutical Branch in Philadelphia, with a completion date of September 2, 2020. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical....
- This federal contract award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,426.80 delivery order contract is for a "Prime Vendor Pharm Branch-Philadelphia" and has a performance period ending on May 5, 2021. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,532.58, is a delivery order for a "Prime Vendor Pharm Branch-Philadelphia," indicating the supply of pharmaceutical products and medical supplies. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,714.14, is a delivery order for a "Prime Vendor Pharm Branch-Philadelphia" with a completion date of February 12, 2021. The contract is a firm fixed-price, full and open competition arrangement, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,374.53, is a delivery order for "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" and has a completion date of February 24, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,800.00 firm fixed-price delivery order is for a "PRIME VENDOR PHARM BRANCH-PHILADELPHIA" and has a performance period that runs through March 2, 2021. Amerisourcebergen Drug Corp, which is a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,825.32, is a delivery order for a "Prime Vendor Pharm Branch-Philadelphia" and has an ultimate completion date of March 19, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. and is registered in the System for Award Management (SAM.gov) as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,924.56 delivery order is for a "Prime Vendor Pharm Branch-Philadelphia" and has a firm fixed price. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. This...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,231.45 firm fixed-price delivery order is for the Prime Vendor Pharmaceutical Branch-Philadelphia program, with a completion date of December 23, 2020. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for a Prime Vendor Pharmaceutical Branch-Philadelphia delivery order valued at $4,632.00, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a performance period through May 20, 2021 and is a firm fixed price delivery order. Amerisourcebergen, through its parent company Cencora, Inc., holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB21FL17XDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,351.00 delivery order contract is for a "Prime Vendor Pharm Branch-Philadelphia" and has a performance period through March 2, 2021. The contract is a firm-fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 3/1/21 |